Clinical Trials Browser

NETWORK × Gynecologic × 1 year × Clear all

NCT05640999 2026-03-10

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Phase 2 Recruiting

393 enrolled

Gynecologic

Endometrial Neoplasms

NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

Phase 2 Active not recruiting

53 enrolled

Gynecologic

Endometrial Neoplasms

NCT05108298 2026-03-02

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Phase NA Recruiting

400 enrolled

BreastCNSDermatologicGastrointestinalGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcoma

Bone Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Leukemia, Lymphoma, Melanoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Pyloric Stenosis, Hypertrophic

NCT04851119 2026-02-24

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Phase 1/2 Recruiting

147 enrolled

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT04918186 2026-02-12

IPROC

Phase 2 Recruiting

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT07397715 2026-02-12

MUSA3

Recruiting

1,000 enrolled

Gynecologic

Uterine Anomalies, Dysmenorrhea, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Myoma, Abdominal Pain, Adenomyoma, Hemostatic Disorders, Adenomyosis

NCT03480776 2026-01-14